Regulatory CMC Consulting for Pharmaceutical & Biotechnology Companies

Regulatory CMC Consulting – From Development to Approval and Beyond

Overcome CMC challenges, strengthen regulatory submissions and reduce avoidable delays on the path to approval.

Polaris Regulatory provides experienced Regulatory CMC strategy, advisory and hands-on support throughout drug development, approval and commercialisation.

We simplify complex issues, bring the right expertise together and help get the critical work done – keeping your programme focused on its next regulatory milestone.

Are CMC Issues Putting Your Next Milestone at Risk?

Even with experienced technical teams, complex regulatory challenges can threaten timelines, budgets and approval readiness.

Common challenges include:

Left unresolved, these issues can lead to costly rework, regulatory questions, missed milestones and delayed approval.

Polaris helps you identify what matters, resolve the obstacles and establish a clear route forward.

Our Approach: Making Complex CMC Challenges Easier to Resolve

Getting a programme ready for regulatory approval requires more than technical advice. It requires the right strategy, the right people and the ability to turn decisions into action.

Our approach combines experienced regulatory judgement with practical, independent support.

Scientists discussing data on a screen at a laboratory workstation
  1. 01. Understand the ChallengeIdentify risks, gaps and critical priorities
  2. 02. Establish the PathwayDevelop a clear, defensible regulatory strategy
  3. 03. Bring People TogetherAlign expertise, decisions and responsibilities
  4. 04. Strengthen the SubmissionMake the scientific evidence clear and coherent
  5. 05. Drive ProgressGet the critical work completed and prepare for what's next
01

Understand What's Really Happening

Identify the issues that could delay your programme.

We review where your programme stands, what needs to be achieved and the technical, regulatory or organisational obstacles threatening progress.

  • Review current CMC strategy and programme readiness
  • Identify critical gaps, risks and unresolved decisions
  • Establish the priorities affecting the next milestone
02

Establish a Clear Regulatory Pathway

Make the right decisions before problems become expensive.

We consider the regulatory requirements, scientific evidence, available options and implications for later development stages.

  • Clarify regulatory expectations and submission requirements
  • Develop practical, scientifically defensible strategies
  • Agree priorities, actions and realistic timelines
03

Bring the Right People Together

Resolve the issues that cannot be solved in isolation.

As an independent specialist, Daniel can work across departmental boundaries, connect technical experts and help resolve competing priorities without becoming caught up in internal structures.

  • Align Regulatory, CMC, Quality, Manufacturing and external partners
  • Clarify responsibilities, decisions and deliverables
  • Resolve disagreements and improve communication
04

Make the Science Clear to Regulators

Help reviewers understand the evidence and regulatory rationale.

A technically sound submission must also tell a clear, coherent scientific story.

We help translate complex technical information into well-structured regulatory documentation that makes the evidence, decisions and control strategies easier to assess.

  • Establish a consistent scientific and regulatory narrative
  • Strengthen CMC submission content and supporting arguments
  • Anticipate likely questions and prepare clear responses
05

Turn Decisions Into Progress

Make sure the agreed work gets done.

Our involvement goes beyond identifying problems and recommending solutions.

We work with your teams to maintain progress, address obstacles, coordinate critical activities and prepare for what comes next.

  • Agree clear actions, responsibilities and milestones
  • Keep critical regulatory work progressing
  • Support submission readiness and future development planning

The outcome: A clearer regulatory pathway, better-coordinated activities, stronger submissions and greater confidence in your next milestone.

Regulatory CMC Services

Our support is tailored to your programme, development stage and existing internal capabilities.

01

Regulatory CMC Strategy & Advisory

Develop global Regulatory CMC strategies, assess development risks, anticipate health authority expectations and make better technical and regulatory decisions.

02

CMC Regulatory Submissions & Approval Support

Prepare and review CMC documentation for IND, CTA, NDA, BLA and MAA submissions, support agency interactions and develop responses to health authority questions.

03

CMC Programme Coordination & Delivery

Coordinate critical CMC activities across internal teams, technical specialists and external manufacturing partners to address obstacles and maintain progress.

04

Fractional & Interim Regulatory CMC Support

Access experienced senior Regulatory CMC expertise for strategic guidance, independent oversight or hands-on delivery without immediately expanding your permanent team.

05

Commercial Readiness & Lifecycle Management

Support the transition to commercial manufacture, post-approval regulatory changes, global market expansion and ongoing product lifecycle requirements.

Experience gained across

Regulatory CMC Support Throughout the Development Journey

Every development milestone creates new regulatory requirements, risks and decisions.
Polaris helps you address today's priorities while preparing for what comes next.

Analytical scientist loading samples into an HPLC system
Milestones 01–04

Development

Build the Right Foundations
  1. Preclinical / IND-Enabling Development
  2. IND / CTA Submission
  3. Phase I
  4. Phase II

Establish phase-appropriate CMC strategies, strengthen analytical and manufacturing controls, prepare clinical submissions and anticipate late-stage requirements.

Binders of regulatory documentation and data under review
Milestones 05–07

Scale & Approval

Strengthen Submission Readiness
  1. Phase III / Pivotal Development
  2. NDA / BLA / MAA Submission
  3. Regulatory Approval & Commercial Launch

Bring together the technical evidence, regulatory documentation and cross-functional activities needed to support submission, regulatory review and commercial readiness.

Gowned operators and QA reviewer on a cleanroom production line
Milestones 08–10

Commercial Growth

Manage Change and Expansion
  1. Post-Approval Change & Lifecycle Management
  2. Geographic Expansion
  3. Product & Portfolio Growth

Navigate manufacturing changes, maintain regulatory compliance, manage commitments and support expansion into new markets and products.

At every stage, two questions guide our approach: What must be achieved now, and what needs to be in place for the next milestone?

Why Work With Polaris?

Independent Perspective

We can challenge assumptions, resolve competing views and focus attention on what is best for the programme.

Deep Regulatory CMC Expertise

Experience across biologics, small molecules, global regulatory submissions, approvals and lifecycle management.

Clarity Without Unnecessary Complexity

We simplify difficult issues while maintaining the scientific rigour and regulatory justification they require.

Calm, Practical Support

We bring considered judgement, clear communication and a solution-focused approach when timelines are tight and pressure is increasing.

Commitment to Getting Things Done

We don't simply provide recommendations. We work alongside your people to help turn decisions into results.

Our philosophy is simple: sound science, straight answers, practical solutions and a commitment to helping clients succeed.

Let's Get Your CMC Programme Ready for Its Next Milestone

Whether you're facing a complex regulatory challenge, preparing a major submission, responding to health authority questions or planning for commercialisation, Polaris can help.

Let's discuss what's holding your programme back, what needs to be achieved and the most practical route forward.